Ganoderma lucidum polysaccharides: Immunomodulation and potential anti-tumor activities

American Journal of Chinese Medicine

Volumn 39, Issue 1, 2011, Pages 15-27

  Xu, Zengtao ^a,b   Chen, Xiuping ^a   Zhong, Zhangfeng ^a   Chen, Lidian ^b   Wang, Yitao ^a  

^a University of Macau   (Macao)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Anti Angiogenesis; Anti Proliferation; Ganoderma lucidum; Immunomodulation; Polysaccharides

Indexed keywords

CYTOKINE; GANODERMA LUCIDUM EXTRACT; GANODERMA LUCIDUM POLYSACCHARIDE; GANOPOLY; GENISTEIN; IMMUNOMODULATING AGENT; POLYSACCHARIDE; TRITERPENOID; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DRUG MECHANISM; GANODERMA LUCIDUM; HUMAN; IMMUNOMODULATION; LOW DRUG DOSE; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; T LYMPHOCYTE;

EID: 78751493724     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11008610     Document Type: Article

References (55)

1. Bao, X.F., X.S. Wang, Q. Dong, J.N. Fang and X.Y. Li. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 59: 175-181, 2002.
2. Baxevanis, C.N., S.A. Perez and M. Papamichail. Cancer immunotherapy. Crit. Rev. Clin. Lab. Sci. 46: 167-189, 2009.
3. Berovic, M., J. Habijanic, I. Zore, B. Wraber, D. Hodzar, B. Boh and F. Pohleven. Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides. J. Biotechnol. 103: 77-86, 2003.
4. Boh, B., M. Berovic, J. Zhang and L. Zhi-Bin. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol. Annu. Rev. 13: 265-301, 2007.
5. Boon, T. and P. van der Bruggen. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183: 725-729, 1996.
6. Bukhman, V.M., E.M. Treshchalina, L.M. Krasnopol'skaia, E.B. Isakova, L.A. Sedakova, A.V. Avtonomova, M.I. Leont'eva, N. Soboleva, I.V. Belitskii and A.V. Bakanov. Preparation and biological properties of basidiomycete aqueous extracts and their mycelial compositions. Antibiot. Khimioter. 52: 4-9, 2007.
7. Cao, L.Z. and Z.B. Lin. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol. Lett. 83: 163-169, 2002.
8. Cao, L.Z. and Z.B. Lin. Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta. Pharmacol. Sin. 24: 321-326, 2003.
9. Cao, Q.Z. and Z.B. Lin. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta. Pharmacol. Sin. 25: 833-838, 2004.
10. Cao, Q.Z. and Z.B. Lin. Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci. 78: 1457-1463, 2006.
11. Chan, W.K., C.C. Cheung, H.K. Law, Y.L. Lau and G.C. Chan. Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function. J. Hematol. Oncol. 1: 9, 2008.
12. Chen, J.H. and R.L. Jiang. A pharmacological study of the Chinese drug lingzhi (ganoderma) (author's transl). Yao Xue Xue Bao. 15: 234-244, 1980.
13. Cheng, K.C., H.C. Huang, J.H. Chen, J.W. Hsu, H.C. Cheng, C.H. Ou, W.B. Yang, S.T. Chen, C.H. Wong and H.F. Juan. Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction. BMC Genomics 8: 411, 2007.
14. Chien, C.M., J.L. Cheng, W.T. Chang, M.H. Tien, C.M. Tsao, Y.H. Chang, H.Y. Chang, J.F. Hsieh, C.H. Wong and S.T. Chen. Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56' NK-cell cytotoxicity in cord blood. Bioorg. Med. Chem. 12: 5603-5609, 2004.
15. Cho, D. and D. Campana. Expansion and activation of natural killer cells for cancer immunotherapy. Korean J. Lab. Med. 29: 89-96, 2009.
16. Gao, Y., H. Gao, E. Chan, W. Tang, A. Xu, H. Yang, M. Huang, J. Lan, X. Li, W. Duan, C. Xu and S. Zhou. Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. Immunol. Invest. 34: 171-198, 2005a.
17. Gao, Y., W. Tang, X. Dai, H. Gao, G. Chen, J. Ye, E. Chan, H.L. Koh, X. Li and S. Zhou. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. J. Med. Food 8: 159-168, 2005b.
18. Gao, Y., S. Zhou, W. Jiang, M. Huang and X. Dai. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol. Invest. 32: 201-215, 2003.
19. Goyos, A. and J. Robert. Tumorigenesis and anti-tumor immune responses in Xenopus. Front. Biosci. 14: 167-176, 2009.
20. Hsiao, W.L., Y.Q. Li, T.L. Lee, N. Li, M.M. You and S.T. Chang. Medicinal mushroom extracts inhibit ras-induced cell transformation and the inhibitory effect requires the presence of normal cells. Carcinogenesis 25: 1177-1183, 2004.
21. Hsu, J.W., H.C. Huang, S.T. Chen, C.H. Wong and H.F. Juan. Ganoderma lucidum polysaccharides induce macrophage-like differentiation in human leukemia THP-1 cells via caspase and p53 activation. Evid. Based Complement. Alternat. Med. 107: 1-13, 2009.
22. Hsu, M.J., S.S. Lee, S.T. Lee and W.W. Lin. Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum. Br. J. Pharmacol. 139: 289-298, 2003.
23. Ji, Z., Q. Tang, J. Zhang, Y. Yang, W. Jia and Y. Pan. Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. J. Ethnopharmacol. 112: 445-450, 2007.
24. Jian-jun, L., L. Lin-sheng, Y. Chuan-lin, Z. Zheng-guang, Z. Qun and W. Shu-guang. Effect of Ganoderma lucidum polysaccharides on tumor cell nucleotide content and cell cycle in S180 ascitic tumor-bearing mice. J. Southern. Med. Uni. 27: 1003-1005, 2007.
25. Jiang, Y., H. Wang, L. Lu and G.Y. Tian. Chemistry of polysaccharide Lzps-1 from Ganoderma lucidum spore and anti-tumor activity of its total polysaccharides. Yao. Xue. Xue. Bao. 40: 347-350, 2005.
26. Kimura, Y., M. Taniguchi and K. Baba. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer. Res. 22: 3309-3318, 2002.
27. Kohguchi, M., T. Kunikata, H. Watanabe, N. Kudo, T. Shibuya, T. Ishihara, K. Iwaki, M. Ikeda, S. Fukuda and M. Kurimoto. Immuno-potentiating effects of the antler-shaped fruiting body of Ganoderma lucidum (Rokkaku-Reishi). Biosci. Biotechnol. Biochem. 68: 881-887, 2004.
28. Lai, S.W., J.H. Lin, S.S. Lai and Y.L. Wu. Influence of Ganoderma lucidum on blood biochemistry and immunocompetence in horses. Am. J. Chin. Med. 32: 931-940, 2004.
29. Li, L., L.S. Lei and C.L. Yu. Changes of serum interferon-gamma levels in mice bearing S-180 tumor and the interventional effect of immunomodulators. Nan Fang Yi Ke Da Xue Xue Bao 28: 65-68, 2008.
30. Lin, K.I., Y.Y. Kao, H.K. Kuo, W.B. Yang, A. Chou, H.H. Lin, A.L. Yu and C.H. Wong. Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1. J. Biol. Chem. 281: 24111-24123, 2006a.
31. Lin, Y.L., S.S. Lee, S.M. Hou and B.L. Chiang. Polysaccharide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper 1 immune response in BALB/c mice. Mol. Pharmacol. 70: 637-644, 2006b.
32. Lin, Y.L., Y.C. Liang, S.S. Lee and B.L. Chiang. Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NFkappaB and p38 mitogen-activated protein kinase pathways. J. Leukoc. Biol. 78: 533-543, 2005b.
33. Lin, Z.B. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J. Pharmacol. Sci. 99: 144-153, 2005a.
34. Lin, Z.B. and H.N. Zhang. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta. Pharmacol. Sin. 25: 1387-1395, 2004.
35. Loose, D. and C. Van de Wiele. The immune system and cancer. Cancer. Biother. Radiopharm. 24: 369-376, 2009.
36. Mahajna, J., N. Dotan, B.Z. Zaidman, R.D. Petrova and S.P. Wasser. Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum. Nutr. Cancer 61: 16-26, 2009.
37. Man, Q et al. The inhibition effect on mouse melanoma cells train by Ganoderma lucidum polysaccharides in vitro. Hebei Med. 15: 400-402, 2009.
38. Miura, T., L. Yuan, B. Sun, H. Fujii, M. Yoshida, K. Wakame and K. Kosuna. Isoflavone aglycon produced by culture of soybean extracts with basidiomycetes and its anti-angiogenic activity. Biosci. Biotechnol. Biochem. 66: 2626-2631, 2002.
39. Ning, J., W. Zhang, Y. Yi, G. Yang, Z. Wu, J. Yi and F. Kong. Synthesis of beta-(1 ! 6)-branched beta-(1 ! 3) glucohexaose and its analogues containing an alpha-(1 ! 3) linked bond with antitumor activity. Bioorg. Med. Chem. 11: 2193-2203, 2003.
40. Paterson, R.R. Ganoderma - a therapeutic fungal biofactory. Phytochemistry. 67: 1985-2001, 2006.
41. Qi-zhen, C., L. Shu-qian, W. Sai-zhen and L. Zhi-bin. Effect of Ganoderma lucidum polysaccharides peptide on invasion of human lung carcinoma cells in vitro. J. Peking. Uni. 39: 653-656, 2007.
42. Shao, B.M., H. Dai, W. Xu, Z.B. Lin and X.M. Gao. Immune receptors for polysaccharides from Ganoderma lucidum. Biochem. Biophys. Res. Commun. 323: 133-141, 2004.
43. Sliva, D. Ganoderma lucidum (Reishi) in cancer treatment. Integr. Cancer. Ther. 2: 358-364, 2003.
44. Tang, Q.J., J.S. Zhang, Y.J. Pan, W. Reutter and H. Fan. Activation of mouse macrophages by the alkali-extracted polysaccharide from spore of Ganoderma lucidum. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 20: 142-144, 2004.
45. Thyagarajan, A., J. Jiang, A. Hopf, J. Adamec and D. Sliva. Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int. J. Mol. Med. 18: 657-664, 2006.
46. Wang, S.Y., M.L. Hsu, H.C. Hsu, C.H. Tzeng, S.S. Lee, M.S. Shiao and C.K. Ho. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer 70: 699-705, 1997.
47. Wei, M.T., K. F. Hua, J. Hsu, A. Karmenyan, K.Y. Tseng, C.H. Wong, H.Y. Hsu and A. Chiou. The interaction of lipopolysaccharide with membrane receptors on macrophages pretreated with extract of Reishi polysaccharides measured by optical tweezers. Opt. Express 15: 11020-11032, 2007.
48. Wicks, S.M., R. Tong, C.Z. Wang, M. O'Connor, T. Karrison, S. Li, J. Moss and C.S. Yuan. Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial. Am. J. Chin. Med. 35: 407-414, 2007.
49. Xie, J.T., C.Z. Wang, S. Wicks, J.J. Yin, J. Kong, J. Li, Y. C. Li and C.S. Yuan. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells. Exp. Oncol. 28: 25-29, 2006.
50. Ying-bo, L., L. Yu-hua, W. Rui and L. Zhi-bin. Effect of Ganoderma lucidum polysaccharides (GlPS) on tumor-endothelium interactions. Chin. Pharmacol. Bull. 39: 250-253, 2008.
51. You, Y.H. and Z.B. Lin. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta. Pharmacol. Sin. 23: 787-791, 2002.
52. Yuen, J.W. and M.D. Gohel. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr. Cancer 53: 11-17, 2005.
53. Zhang, J., Q. Tang, M. Zimmerman-Kordmann, W. Reutter and H. Fan. Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Sci. 71: 623-638, 2002.
54. Zhu, X.L., A.F. Chen and Z.B. Lin. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J. Ethnopharmacol. 111: 219-226, 2007.
55. Zjawiony, J.K. Biologically active compounds from Aphyllophorales (polypore) fungi. J. Nat. Prod. 67: 300-310, 2004.